iHealthScreen
iHealthScreen Inc. is a health technology company that develops innovative AI-based software for early screening, diagnosis, and prediction of retinal and systemic diseases such as Diabetic Retinopathy (DR), Age-Related Macular Degeneration (AMD), Glaucoma, stroke, heart disease, and Alzheimer's disease. Their products include AI-powered retinal image grading tools, electronic health record (EHR) solutions, telemedicine platforms, and image analyzers for retinal pathology and vessel analysis. The company aims to provide accessible, low-cost, and accurate screening in primary care settings to prevent blindness and save lives, with regulatory approvals in Europe, UK, Australia, and UAE, and FDA 510K submissions. iHealthScreen has secured significant research funding, partnerships with major hospitals like Mount Sinai, and collaborations with diabetes societies to screen millions of at-risk patients globally, positioning it as a leader in AI-driven healthcare screening and telemedicine.
iHealthScreen
iHealthScreen Inc. is a health technology company that develops innovative AI-based software for early screening, diagnosis, and prediction of retinal and systemic diseases such as Diabetic Retinopathy (DR), Age-Related Macular Degeneration (AMD), Glaucoma, stroke, heart disease, and Alzheimer's disease. Their products include AI-powered retinal image grading tools, electronic health record (EHR) solutions, telemedicine platforms, and image analyzers for retinal pathology and vessel analysis. The company aims to provide accessible, low-cost, and accurate screening in primary care settings to prevent blindness and save lives, with regulatory approvals in Europe, UK, Australia, and UAE, and FDA 510K submissions. iHealthScreen has secured significant research funding, partnerships with major hospitals like Mount Sinai, and collaborations with diabetes societies to screen millions of at-risk patients globally, positioning it as a leader in AI-driven healthcare screening and telemedicine.